Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
-
* Corresponding author: Maria E Ramos-Nino Maria.Ramos@uvm.edu
- Equal contributors
BMC Medicine 2007, 5:17 doi:10.1186/1741-7015-5-17
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 04 Nov 2006 | |
| Reviewer's Report | Takuji Tanaka | 04 Dec 2006 | |
| Reviewer's Report | Lisa Yee | 19 Jan 2007 | |
| Reviewer's Report | Adriana Perez | 21 Feb 2007 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 04 Mar 2007 |
| Reviewer's Report | Adriana Perez | 27 Mar 2007 | |
| Reviewer's Report | Lisa Yee | 28 Mar 2007 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 23 Apr 2007 |
| Reviewer's Report | Adriana Perez | 09 May 2007 | |
| Reviewer's Report | Lisa Yee | 21 May 2007 | |
| Resubmission - Version 6 | Manuscript | Author's comment | 01 Jun 2007 |
| Editorial acceptance | 08 Jun 2007 | ||
| Published | 21 Jun 2007 |